Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pediatric groups infant

Vaccines are used in either the general population of children or adults or for special groups. Recommendations for vaccine usage are made by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control. The Committee on Infectious Diseases of the American Academy of Pediatrics (Redbook Committee) also makes recommendations for infants through adolescents, and the American Academy of Family Physicians makes recommendations for adults. An excellent review of vaccine history, development, usage, and related regulatory issues is available (2). [Pg.356]

Owen, M.J., et al. (1993). Relation of infant feeding practices cigarette smoke exposure and group children care to the onset and duration of otitis media with effusion in the first years of life, J. Pediatric., 123, 702-710. [Pg.124]

Physiologic processes that influence pharmacokinetic variables in the infant change significantly in the first year of life, particularly during the first few months. Therefore, special attention must be paid to pharmacokinetics in this age group. Pharmacodynamic differences between pediatric and other patients have not been explored in great detail and are probably small except for those specific target tissues that mature at birth or immediately thereafter (eg, the ductus arteriosus). [Pg.1266]

Connor EM, Sperhng RS, Gelber R, Kiselev P, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol, 076 study group. NEJM. 331 1173-1180. [Pg.197]

To better understand changes in drug disposition, the pediatric population needs to be categorized into various groups (Table 1) because children vary markedly in their absorption, distribution, metabolism, and elimination of medications. This occurs because neonates, infants, children, adolescents, and adults have different body compositions (i.e., as to their percentages of body water and fat) and have their body organs in different stages of development. [Pg.2630]

Peltola H, Safary A, Kayhty H, Karanko V, Andre FE. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics 1985 76(l) 91-6. [Pg.2253]

Finer NN, Vohr BR, Robertson CMT, Ehrenkranz RA, Verter J, Wright LL, Hoffman HJ, Walsh-Sukys MC, Dusick AM, Fleisher BE, et al. Inhaled nitric oxide in term and near-term infants neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000 136(5) 611-17. [Pg.2541]

Meurs KP, Rhine WD, AsseUn JM, Durand DJ, Peverinj R, Linda L, Dudell G, Butler S. Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO CoUaborative Group. Pediatr Pulmonol 1997 24(5) 319-23. [Pg.2541]

Janousek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European Retrospective Multicenter Study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Am J Cardiol 1998 81(9) 1121. ... [Pg.2944]

Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, Culnane M, Coombs RW, Scott G, Van Dyke RB, Shearer WT, Jimenez E, Diaz C, Harrison DD, Delfraissy JF. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 1998 12(14) 1805-13. [Pg.3717]

Huang NN, High RN. Comparison of semm levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr 1953 42 657-668. [Pg.99]

The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial vims monoclonal antibody, reduces hospitalization from respiratory syncytial vims infection in high-risk infants. Pediatrics 1998 102 531-537. [Pg.1961]

Schwartz EM, Rae WA Effect of polybrominated biphenyls (PBB) on developmental abilities in young children. Am J Public Health 73 277-281,1983 Seagull E Developmental abilities of children exposed to polybrominated biphenyls (PBB). Am J Public Health 73 281-285, 1983 Stross JK, Nixon RK, Anderson MD Neuropsychiatric findings in patients exposed to polybrominated biphenyls. Ann N Y Acad Sci 320 368-372,1979 Valciukas JA, Lilis R, Wolff MS, et al Comparative neurobehavioral study of a polybrominated biphenyl-exposed population in Michigan and a nonexposed group in Wisconsin. Environ Health Perspect 23 199-210,1978 Valciukas JA, Lilis R, Anderson HA, et al The neurotoxicity of polybrominated biphenyls results of a medical field survey. Ann N Y Acad Sci 320 337-367, 1979 Weil WB, Spencer M, Benjamin D, et al The effect of polybrominated biphenyls on infants and young children. J Pediatr 98 47-51,1981... [Pg.258]

Pediatric Dose. The amount of radioactivity for infants and children is based on body weight (static imaging). Recommendations by the Pediatric Task Group of the European Association of Nuclear Medicine (EANM), based on body weight should be followed (see Appendix 1, Table A1.2). [Pg.293]


See other pages where Pediatric groups infant is mentioned: [Pg.998]    [Pg.115]    [Pg.1398]    [Pg.1406]    [Pg.70]    [Pg.110]    [Pg.469]    [Pg.153]    [Pg.928]    [Pg.929]    [Pg.934]    [Pg.361]    [Pg.362]    [Pg.2629]    [Pg.2645]    [Pg.1572]    [Pg.1607]    [Pg.2251]    [Pg.2790]    [Pg.3327]    [Pg.225]    [Pg.228]    [Pg.656]    [Pg.678]    [Pg.226]    [Pg.91]    [Pg.2592]    [Pg.2597]    [Pg.207]   
See also in sourсe #XX -- [ Pg.998 ]




SEARCH



Infants

Pediatric groups

Pediatrics

© 2024 chempedia.info